Ezetimibe final guidance [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2019-09-30 17:33 (1456 d 18:17 ago) – Posting: # 20658
Views: 3,900

Dear Ohlbe,

I agree with your points about error, etc.

❝ But if you directly measure total (after deconjugation), and then calculate the glucuronide by substracting unconjugated from total, you won't have this problem. The increased error will affect the glucuronide, but you don't use these concentrations for the determination of bioequivalence.


❝ Wouldn't this be acceptable ?


I don’t know what is acceptable for the agencies. For me, absolutely. I still don’t get the point why one has to present the aglycone at all. Heck, it is not used in the BE assessment.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,759 posts in 4,775 threads, 1,628 registered users;
13 visitors (0 registered, 13 guests [including 5 identified bots]).
Forum time: 11:50 CEST (Europe/Vienna)

Whenever a theory appears to you as the only possible one,
take this as a sign that you have neither understood the theory
nor the problem which it was intended to solve.    Karl R. Popper

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5